切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2021, Vol. 14 ›› Issue (02) : 253 -255. doi: 10.3877/cma.j.issn.1674-6902.2021.02.031

综述

高毒力肺炎克雷伯菌的研究进展
张慧芳1, 王瑞兰1,()   
  1. 1. 201620 上海,上海交通大学附属第一人民医院急诊危重病科
  • 收稿日期:2020-11-21 出版日期:2021-04-25
  • 通信作者: 王瑞兰
  • 基金资助:
    上海科学技术委员会科技支撑项目(18411950620)

Research Progress of Klebsiella pneumonia

Huifang Zhang1, Ruilan Wang1()   

  • Received:2020-11-21 Published:2021-04-25
  • Corresponding author: Ruilan Wang
引用本文:

张慧芳, 王瑞兰. 高毒力肺炎克雷伯菌的研究进展[J]. 中华肺部疾病杂志(电子版), 2021, 14(02): 253-255.

Huifang Zhang, Ruilan Wang. Research Progress of Klebsiella pneumonia[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2021, 14(02): 253-255.

1
Akova M, Daikos GL, Tzouvelekis L, et al. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria[J]. Clin Microbiol Infect, 2012, 18(5): 439-448.
2
胡付品,郭 燕,朱德妹,等. 2016年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志,2017, 17(5): 481-491.
3
Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis[J]. Arch Intern Med, 1986, 146(10): 1913-1916.
4
Wu H, Li DD, Zhou HJ, et al. Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae[J]. Microb Pathog, 2017, 104: 254-262.
5
Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae[J]. Clin Microbiol Rev, 2019, 32(3): e00001-19.
6
Jervey LP Jr. The treatment of acute friedlaender′s bacillus pneumonia;a continuing problem[J]. AMA Arch Intern Med, 1957, 99(1): 1-7.
7
Ritvo M, Martin F. The clinical and roentgen manifestations of pneumonia due to Bacillus mucosus capsulatus (primary Friedlander pneumonia)[J]. Am J Roentgenol Radium Ther, 1949, 62(2): 211-222.
8
Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?[J]. Gut, 2002, 50(3): 420-424.
9
Bensley EH. A Case of Friedlander's Pneumonia[J]. Can Med Assoc J , 1932, 26(6): 681-684.
10
Lam MMC, Wyres KL, Duchene S, et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination[J]. Nat Commun, 2018, 9(1): 2703.
11
Nassif X, Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin[J]. Infect Immun, 1986, 54(3): 603-608.
12
Nassif X, Honore N, Vasselon T, et al. Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae[J]. Mol Microbiol, 1989, 3(10): 1349-1359.
13
Chen YT, Chang HY, Lai YC, et al. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43[J]. Gene, 2004, 337: 189-198.
14
Wu KM, Li LH, Yan JJ, et al. Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis[J]. J Bacteriol, 2009, 191(14): 4492-4501.
15
Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study[J]. Lancet Infect Dis, 2018, 18(1): 37-46.
16
Yu WL, Ko WC, Cheng KC, et al. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes[J]. Diagn Microbiol Infect Dis, 2008, 62(1): 1-6.
17
Guo C, Yang X, Wu Y, et al. MLST-based inference of genetic diversity and population structure of clinical Klebsiella pneumoniae, China[J]. Sci Rep, 2015, 5: 7612.
18
Russo TA, Olson R, Fang CT, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae[J]. J Clin Microbiol, 2018, 56(9).
19
Kloos WE, Musselwhite MS. Distribution and persistence of staphylococcus and micrococcus species and other aerobic bacteria on human skin[J]. Appl Microbiol, 1975, 30(3): 381-385.
20
Haryani Y, Noorzaleha AS, Fatimah A B, et al. Incidence of Klebsiella pneumonia in street foods sold in Malaysia and their characterization by antibiotic resistance, plasmid profiling, and RAPD-PCR analysis[J]. Food Control, 2007, 18(7): 847-853.
21
Chung DR, Lee H, Park MH, et al. Fecal carriage of serotype K1 Klebsiella pneumoniae ST23 strains closely related to liver abscess isolates in Koreans living in Korea[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(4): 481-486.
22
Lin YT, Wang YP, Wang FD, et al. Community-onset Klebsiella pneumoniae pneumonia in Taiwan: clinical features of the disease and associated microbiological characteristics of isolates from pneumonia and nasopharynx[J]. Front Microbiol, 2015, 9: 122.
23
Zhang Y, Zhao C, Wang Q, et al. High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic distribution, clinical characteristics, and antimicrobial resistance[J]. Antimicrob Agents Chemother, 2016, 60(10): 6115-6120.
24
Yan Q, Zhou M, Zou M, et al. Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China[J]. Eur J Clin Microbiol Infect Dis, 2016, 35(3): 387-396.
25
Liu YM, Li BB, Zhang YY, et al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China[J]. Antimicrob Agents Chemother, 2014, 58(9): 5379-5385.
26
Li W, Sun G, Yu Y, et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China[J]. Clin Infect Dis, 2014, 58(2): 225-232.
27
Khaertynov KS, Anokhin VA, Davidyuk YN, et al. Case of meningitis in a neonate caused by an extended-spectrum-beta-lactamase-producing strain of hypervirulent klebsiella pneumoniae[J]. Front Microbiol, 2017, 8: 1576.
28
Surgers L, Boyd A, Girard PM, et al. ESBL-producing strain of hypervirulent Klebsiella pneumoniae K2, France[J]. Emerg Infect Dis, 2016, 22(9): 1687-1688.
29
Shankar C, Santhanam S, Kumar M, et al. Draft genome sequence of an extended-spectrum-beta-lactamase-positive hypervirulent Klebsiella pneumoniae strain with novel sequence type 2318 isolated from a neonate[J]. Genome Announc, 2016, 4(6): e01273-16.
30
Yao B, Xiao X, Wang F, et al. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China[J]. Int J Infect Dis, 2015, 37: 107-112.
31
Mohammad Ali Tabrizi A, Badmasti F, Shahcheraghi F, et al. Outbreak of hypervirulent Klebsiella pneumoniae harbouring blaVIM-2 among mechanically-ventilated drug-poisoning patients with high mortality rate in Iran[J]. J Glob Antimicrob Resist, 2018, 15: 93-98.
32
Roulston KJ, Bharucha T, Turton JF, et al. A case of NDM-carbapenemase-producing hypervirulent Klebsiella pneumoniae sequence type 23 from the UK[J]. JMM Case Rep, 2018, 5(9): e005130.
33
Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study[J]. Lancet Infect Dis, 2016, 16(2): 161-168.
34
Gu DX, Huang YL, Ma JH, et al. Detection of colistin resistance gene mcr-1 in hypervirulent Klebsiella pneumoniae and escherichia coli isolates from an infant with diarrhea in China[J]. Antimicrob Agents Chemother, 2016, 60(8): 5099-5100.
35
Choi MJ, Ko KS. Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains[J]. Antimicrob Agents Chemother, 2015, 59(11): 6763-6773.
36
Huang YH, Chou SH, Liang SW, et al. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan[J]. J Antimicrob Chemother, 2018, 73(8): 2039-2046.
37
Goncalves GB, Furlan JPR, Vespero EC, et al. Spread of multidrug-resistant high-risk Klebsiella pneumoniae clones in a tertiary hospital from southern Brazil[J]. Infect Genet Evol, 2017, 56: 1-7.
38
Martin RM, Cao J, Brisse S, et al. Molecular Epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae[J]. mSphere, 2016, 1(5): e00261-16.
[1] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[2] 涂家金, 廖武强, 刘金晶, 涂志鹏, 毛远桂. 严重烧伤患者鲍曼不动杆菌血流感染的危险因素及预后分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 491-497.
[3] 李维, 莫俊俏. 儿童呼吸道耐药流感嗜血杆菌基因型鉴定及耐药分析对抗菌药物治疗选择的意义[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 315-323.
[4] 张小曼, 马筱秋, 许正锯, 张纯瑜, 何彩婷. 乙型肝炎病毒逆转录酶区耐药突变对血清乙型肝炎病毒表面抗原水平的影响[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 324-332.
[5] 张海金, 王增国, 蔡慧君, 赵炳彤. 2020至2022年西安市儿童医院新生儿细菌感染分布及耐药监测分析[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 222-229.
[6] 曹长青, 郭新艳, 高源, 张存, 唐海利, 樊东, 杨小军, 张松, 赵华栋. 肿瘤微环境参与介导HER2阳性乳腺癌曲妥珠单抗耐药的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 90-95.
[7] 刘付有欢, 吴秀芹, 邓翠婷, 苏青. 基于模型的西妥昔单抗治疗胃癌细胞系的反应和耐药因素分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 385-388.
[8] 胡皓翀, 刘一霆, 郭嘉瑜, 邹寄林, 陈忠宝, 周江桥, 邱涛. 肾移植术后耐碳青霉烯类肺炎克雷伯菌感染的诊疗分析[J]. 中华移植杂志(电子版), 2023, 17(04): 246-249.
[9] 王晓丹, 王媛, 崔向宇, 任晓磊. 上尿路结石内镜手术后尿源性脓毒血症病原菌耐药及死亡高危因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 611-615.
[10] 王庆, 张红联, 吴志勇. COPD合并多重耐药菌肺部感染预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 557-559.
[11] 卞天丹, 宋爽, 陶臻. 高毒力肺炎克雷伯菌分子学机制研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 438-441.
[12] 王甜甜, 温媛, 李振, 叶美红, 郭影, 马双. 和厚朴酚调控Nrf2/ARE通路对胃癌细胞的顺铂化疗敏感性的影响[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 202-209.
[13] 李静静, 翟蕾, 赵海平, 郑波. 多囊肾合并囊肿的多重耐药菌感染一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 920-923.
[14] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[15] 林舒楠, 党文强, 钟天, 梁斯欣, 张磊, 唐晓华, 袁文常. 2017—2021年广东地区基层医疗机构金黄色葡萄球菌临床分离株耐药谱分析[J]. 中华临床实验室管理电子杂志, 2023, 11(03): 139-144,150.
阅读次数
全文


摘要